SanegeneBio
Phase 1SanegeneBio is revolutionizing RNAi-powered therapies for metabolic and autoimmune diseases through their Ligand and Enhancer Assisted (LEAD™) Technology.
Founded
2018
Focus
RNA & Gene Therapy
About
SanegeneBio is revolutionizing RNAi-powered therapies for metabolic and autoimmune diseases through their Ligand and Enhancer Assisted (LEAD™) Technology.
Funding History
1Total raised: $5.5M
Seed$5.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile